To compare the efficacy of intravenous methylprednisolone and intravenous dexamethasone for the treatment of optic neuritis in terms of visual recovery and side-effects and to evaluate the clinical profile of optic neuritis patients admitted in BPKLCOS. 60 patients of acute idiopathic typical optic neuritis presenting to our centre were included in this prospective, randomized comparative study. Study population was randomly divided into two groups. Group I received intravenous dexamethasone 200 mg once daily for three days and Group II received intravenous methylprednisolone 500 mg/twelvehourly for three days followed by oral prednisolone for 11 days. Optic neuritis was found to be common in the age group of 21 to 30 years with female preponderance. The most frequent mode of presentation was abrupt loss of vision. Retrobulbar optic neuritis dominated the study group. Both groups were age and sex-matched. The mean presenting visual acuity in group I was 0.065±0.59. The mean presenting visual acuity in group II was 0.1±0.15. On day 90 of steroid therapy, visual acuity improved to 0.98±0.073 in Group I and 0.88±0.16 in Group II (p=0.23). At three months, there was statistically significant improvement in both groups in terms of colour vision, contrast sensitivity and Goldmann visual fields as well but difference between the two groups was statistically insignificant. Intravenous dexamethasone is an effective treatment for optic neuritis, which is comparable to intravenous methylprednisolone. However, larger studies are required to establish it as a safe, inexpensive and effective modality for the treatment of optic neuritis.
INTRODUCTION
Optic neuritis is known to improve without treatment though it may also result in long-lasting defects in visual acuity and abnormalities in contrast sensitivity, color vision, stereopsis, light sensitivity, visual fields, pupillary responses, optic disc appearance and visual evoked potentials. 1, 2 The treatment of optic neuritis has always been controversial regarding the use of steroids. 3 Intravenous megadose steroids help towards an early recovery of vision and offer some advantage in preventing recurrence and development of multiple sclerosis.
prednisolone on visual recovery as well as to evaluate their side effects.
AIMS AND OBJECTIVES
To prepare clinical profile of optic neuritis cases and compare the efficacy of treatment with intravenous dexamethasone and intravenous methylprednisolone
RESEARCH METHODOLOGY
Study design: A hospital based prospective randomized comparative study. 
Inclusion criteria:
All cases of optic neuritis presenting to the OPD and Neuro-Ophthalmology clinic of BPKLCOS and receiving treatment in TUTH.
Exclusion criteria:
• Patients who received some form of treatment elsewhere.
• Patients who were not treated as per the treatment protocol.
• Patients who refused to participate in the study.
• Visual loss due to trauma/traumatic optic neuropathy
• Patients not completing the follow up during the study period.
METHODOLOGY:
Patients were randomized into two groups for treatment with systemic corticosteroids by block randomization.
Group I: Patients in group I received intravenous dexamethasone 200 mg (in 150 ml 5% dextrose solution) given over one and a half to two hours once a day for three days.
Group II: Patients in group II received intravenous methylprednisolone 500mg/twelve-hourly (in 150 ml 5% dextrose solution) given over one and a half to two hours for three days followed by oral prednisolone for 11 days.
Visual acuity was assessed using snellen Chart (at a distance of 6m). Colour vision was recorded using Ishihara Pseudoisochromatic colour vision plates.
Contrast sensitivity was recorded using Pelli-Robson chart at 1m. Goldman visual field using Goldman perimeter for both the eyes were done.
The patients in both groups were examined every day during the institution of treatment and later at one week, one month and three months.
Data were recorded on a pre-designed proforma.
Data processing and analysis:
Useful data were entered in computer database for statistical analysis. Microsoft Excel version 2007
and SPSS version14.0.1software were used for this purpose. In this study,P value <0.05 was considered statistically significant.
RESULTS
A total of 60 patients were included in the study.
The patients were divided into two groups of 30 each, group I received Dexamethasone therapy while Group II received Methylprednisolone therapy.
AGE
Age of the patients ranged from 15 to 62 years in group I while 10 to 60 in group II. 
Clinical diagnosis:
40%(n=12) patients in group I were diagnosed as papillitis; 60%(n=18) were diagnosed as retrobulbar optic neuritis.
In group II, 50%(n=15) were diagnosed as papillitis, 46.6%(n=14) as retrobulbar optic neuritis and 3.3%(n=1) patient was diagnosed to have neuroretinitis at presentation.
Visual status:
At presentation in group I, two eyes had no light perception (NPL) at all, nineteen eyes had less than 3/60 vision and eighteen eyes had vision of 6/24-6/60.
At subsequent follow ups, the visual acuity showed improvement in all patients so that at the end of three months follow up, all forty two eyes had a vision of 6/6-6/18. The p value was <0.001 at each subsequent follow up which was statistically significant. 14.2%
(n=6) eyes had vision of 6/6, 16.6% (n=7) eyes had vision of 6/9, 35.7% (n=15) eyes had vision of 6/12 while 33.3% (n=14) eyes had vision of 6/18 in Group I at 3 months follow up.
In group II, two eyes were NPL at presentation, twenty eyes had vision of less than 3/60, one eye had vision of 5/60-3/60, fourteen eyes had vision of 6/24-6/60 and three eyes had 6/6-6/18 vision. All patients showed improvement in visual acuity so that at the end of three months follow up, all forty eyes had a vision of 6/6-6/18. The p value at each follow up was less than 0.001 which was statistically significant. In Group II, 17.5% (n=7) eyes had vision of 6/6, 12.5% (n=5) eyes had vision of 6/9, 35% (n=14) eyes had vision of 6/12 and 35% (n=14) eyes had vision of 6/18 at 3 months follow up.
While comparing the p value between group I and II, it was 0.14 at pretreatment period. At first week, first month and 3 rd month follow up, it was 0.59, 0.43 and 0.36 respectively, which means the p value is statistically insignificant. Hence Dexamethasone and Methylprednisolone have equal efficacy in the outcome of the visual acuity upto 3 months follow up.
Colour vision at presentation and on subsequent follow ups:
Among the study population, in group I twenty two eyes had normal colour vision, ten had abnormal colour vision while in rest ten eyes colour vision could not be done because of poor visual acuity. At the end of three months after treatment with intravenous dexamethasone, 95.2%(n=40) of the eyes in group I had normal colour vision .
In group II, nine eyes had normal colour vision, eleven eyes had abnormal colour vision while colour vision testing could not be done in twenty eyes because of poor visual acuity. After treatment with intravenous methylprednisolone, colour vision showed improvement in all eyes so that at the end of three months follow up,97.5%(n=39) of the eyes had normal colour vision while one eye had abnormal colour vision.
Contrast sensitivity:
The patients who had very poor visual acuity could not be tested for contrast sensitivity.
The p value at each follow up is significant in each group suggestive of recovery of contrast sensitivity from previous records. years to 46 years. 13 Study done by Wang et al (2001) showed that mean age was 39.1 years and age range from 11 to 67 years.
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Unilateral optic neuritis, 63.3% (n=38) dominated our study group. In total retrobulbar neuritis was the more common presentation though in group II papillitis was diagnosed in 50% of the cases while had absolute colour deficiency. 10 The ONTT (1992) showed that most persons show mixed red-green and blue-yellow colour defects. 13 Blue yellow defects tend to be slightly more common in the acute phase of the disease, with slightly more red green defects at 6 months. Person may shift defect type over time.
It concluded that optic neuritis is not characterized by selective red green defects. Colour defect type cannot be used for the differential diagnosis of optic neuritis.
A study done by Mehrotra A. et al (2007), which compared the efficacy of Dexamethasone with
Methylprednisolone also found similar results.
There was no significant difference in the relative improvement of contrast sensitivity in that study. 
CONCLUSION
Intravenous dexamethasone is as effective as megadose intravenous methylprednisolone.
Therefore, Dexamethasone can be considered as an alternative to methylprednisolone for treatment of optic neuritis.
